(Q47895551)

6 February 2018

title

Dual-chamber pacing for hypertrophic cardiomyopathy: a randomized, double-blind, crossover trial (English)

1 reference

6 February 2018

hypertrophic cardiomyopathy

main subject

1 reference

8

Tajik AJ

1 reference

6 February 2018

Sharonne N. Hayes

6

object named as

Hayes SN

1 reference

6 February 2018

author name string

Nishimura RA

1

1 reference

6 February 2018

Trusty JM

2

1 reference

6 February 2018

Hayes DL

3

1 reference

6 February 2018

Ilstrup DM

4

1 reference

6 February 2018

Larson DR

5

1 reference

6 February 2018

Allison TG

7

1 reference

6 February 2018

language of work or name

English

0 references

publication date

1 February 1997

1 reference

6 February 2018

Journal of the American College of Cardiology

published in

1 reference

6 February 2018

volume

29

1 reference

6 February 2018

issue

2

1 reference

6 February 2018

page(s)

435-441

1 reference

6 February 2018

Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900473-1

7 January 2021

Impact of dual-chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and beta-adrenergic blocker therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900473-1

7 January 2021

Effects of dual-chamber pacing in hypertrophic obstructive cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900473-1

7 January 2021

Hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900473-1

7 January 2021

Echocardiographic and Doppler assessment of hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900473-1

7 January 2021

Doppler echocardiographic determination of the pressure gradient in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900473-1

7 January 2021

Intraoperative Doppler echocardiography in hypertrophic cardiomyopathy: correlations with the obstructive gradient

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900473-1

7 January 2021

Evaluation of hypertrophic cardiomyopathy by Doppler color flow imaging: initial observations

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900473-1

7 January 2021

Noninvasive assessment of left ventricular diastolic function by pulsed Doppler echocardiography in patients with hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900473-1

7 January 2021

Assessment of diastolic function of the heart: background and current applications of Doppler echocardiography. Part II. Clinical studies

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900473-1

7 January 2021

Assessment of diastolic function of the heart: background and current applications of Doppler echocardiography. Part I. Physiologic and pathophysiologic features

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900473-1

7 January 2021

Quantitative hemodynamics by Doppler echocardiography: a noninvasive alternative to cardiac catheterization

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900473-1

7 January 2021

Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900473-1

7 January 2021

Effect of dual-chamber pacing on systolic and diastolic function in patients with hypertrophic cardiomyopathy. Acute Doppler echocardiographic and catheterization hemodynamic study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900473-1

7 January 2021

Mechanism of hemodynamic improvement by dual-chamber pacing for severe left ventricular dysfunction: an acute Doppler and catheterization hemodynamic study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900473-1

7 January 2021

Dual chamber pacing for hypertrophic obstructive cardiomyopathy: has its time come?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900473-1

7 January 2021

The importance of placebo effects in pain treatment and research

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900473-1

7 January 2021

The placebo effect: can we use it better?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900473-1

7 January 2021

Is there logic in the placebo?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900473-1

7 January 2021

Differences in coronary flow and myocardial metabolism at rest and during pacing between patients with obstructive and patients with nonobstructive hypertrophic cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900473-1

7 January 2021

Long-term follow-up of patients undergoing myotomy/myectomy for obstructive hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900473-1

7 January 2021

Effect of surgical reduction of left ventricular outflow obstruction on hemodynamics, coronary flow, and myocardial metabolism in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900473-1

7 January 2021

Current operative treatment of obstructive hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900473-1

7 January 2021

Hypertrophic obstructive cardiomyopathy: ten- to 21-year follow-up after partial septal myectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900473-1

7 January 2021

10.1016/S0735-1097(96)00473-1

Identifiers

DOI

1 reference

6 February 2018

1 reference

6 February 2018